Drug Database
Back to search

Poland· PL-100195816

Panzol

A pantoprazole product containing pantoprazolum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.

ATC A02BC02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPanzolATCA02BC02REGISTER NO.PL-100195816PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pantoprazolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pantoprazole is registered in 18 of 19 countries.

Countries holding a registration under ATC A02BC02 (pantoprazole), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose
Search pantoprazole products by name

Pantoprazole · ATC A02BC02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pantoprazole costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.14 in France to $0.65 in Switzerland — a ×4.8 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pantoprazole · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.65
  • ES Spain$0.36
  • IT Italy$0.24
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Pantoprazolum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
A02BC02
ATC class
Pantoprazole
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

2 priced
  • gtin
    05909990652303
  • gtin
    05909990652327
  • gtin
    05909990652334
    28 szt.
    PLN 10.03
  • gtin
    05909991069681
    56 szt.
    PLN 13.94
  • gtin
    05909990652341

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

720 interactions on record for pantoprazole.

Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pantoprazole against other medicinesHow interaction checks work

Pantoprazole · interactions on record

720 records

  • 21 severe
  • 115 moderate
  • 30 minor
  • 545 info

Most severe, free to view

  • NelfinavirJ05AE04severe
  • AtazanavirJ05AE08severe
  • RilpivirineJ05AG05severe
  • Sofosbuvir and velpatasvirJ05AP55severe

9 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A02BC02

Pantoprazole, as other registers publish it.

All pantoprazole products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c47742cf-80c1-4f77-be87-edac0493b898
GET /v1/drugs/c47742cf-80c1-4f77-be87-edac0493b898?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki dojelitowe",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "05909990652303 ¦ Rp ¦ Skasowane ¦ 44305\n14 tabl. (1 x 14)\n05909990652327 ¦ Rp ¦ Skasowane ¦ 44306\n14 tabl. (2 x 7)\n05909990652341 ¦ Rp ¦ 44307\n28 tabl. (4 x 7)\n05909990652334 ¦ Rp ¦ 44310\n28 tabl. (2 x 14)\n05909991069681 ¦ Rp ¦ 85043\n56 tabl.",
  "substance": "Pantoprazolum 20 mg",
  "common_name": "Pantoprazolum",
  "pl_product_id": "100195816",
  "pozwolenie_nr": "14685",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about pantoprazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console